まずはこれだけ！　抗菌薬の選び方と使い方のシンプルメソッド

出版社： 羊土社
著者：
発行日： 2024-04-20
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784758123600
電子書籍版： 2024-04-20 （第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

5,280 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,280 円(税込)

購入する

商品紹介

「感染症診療のロジック」がわかれば抗菌薬選択に自信がもてる！幅広い診療現場で役立つので，外来医はもちろん，研修医・訪問診療医や，薬剤師・看護師・臨床検査技師などのメディカルスタッフの方々にもおすすめ！

目次

  • 付 録
    (1)感染症診療のフローチャート
    (2)感染症診療シート
    (3)主要抗菌薬一覧
    (4)グラム染色分類
    略語一覧

    第１章　総論～感染症診療の流れ
    　1　はじめに：抗菌薬使用のルーチンワーク ～誰もが実践できる，適切なアプローチ
    　2　感染症診断のための発熱アプローチ4ステップ
    　3　診断：最低限必要なものは？
    　4　原因微生物の推定をしよう ～最低限押さえておくべき微生物の基本知識
    　5　初学者が押さえておくべき抗菌薬の各論
    　6　ソース・コントロール評価 ～抗菌薬以外に大切な治療成功要因
    　7　重症度評価と抗菌薬の初期選択の方法 ～起因菌のカバー範囲を決める
    　8　治療効果判定 ～臨床経過は「改善，横ばい，悪化」のうちのどれ？

    第２章　市中で感染症を診る～症候／疾患別アプローチ
    　1　肺炎アプローチ ～「発熱＋咳嗽＋呼吸困難」症例の対応
    　2　尿路感染症（膀胱炎，腎盂腎炎，前立腺炎）アプローチ ～主訴が「発熱のみ」症例の対応
    　3　胆道感染症（胆嚢炎，胆管炎）アプローチ ～患者因子が複雑な症例への対応
    　4　蜂窩織炎アプローチ ～クラスター化が重要な症例への対応

    第３章　これだけはダメ！ 外来での感染症診療におけるNG行動
    　1　ウイルス感染症疑いに抗菌薬を投与する
    　2　フォーカス不明型に精査をせずに抗菌薬を投与する
    　3　不明熱型に精査をせずに抗菌薬を投与する

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 総論～感染症診療の流れ

P.61 掲載の参考文献
1) Opal SM & Pop-Vicas A : Molecular Mechanisms of Antibiotic Resistance in Bacteria.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp222-239, Elsevier, 2019
 
2) Massova I & Mobashery S : Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrob Agents Chemother, 42 : 1-17, 1998 [PMID : 9449253]
 
3) Yoshihara E, et al : Protein D2 porin of the Pseudomonas aeruginosa outer membrane bears the protease activity. FEBS Lett, 394 : 179-182, 1996 [PMID : 8843159]
 
4) Li XZ, et al : The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev, 28 : 337-418, 2015 [PMID : 25788514]
 
5) Bush K & Jacoby GA : Updated functional classification of beta-lactamases. Antimicrob Agents Chemother, 54 : 969-976, 2010 [PMID : 19995920]
 
6) De Angelis G, et al : Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae. Int J Mol Sci, 21 : 5090, 2020 [PMID : 32708513]
 
7) Doi Y : Penicillins and s-Lactamase Inhibitors.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp251-267, Elsevier, 2019
 
8) Drawz SM & Bonomo RA : Three decades of beta-lactamase inhibitors. Clin Microbiol Rev, 23 : 160-201, 2010 [PMID : 20065329]
 
9) Bonnet R : Growing group of extended-spectrum beta-lactamases : the CTX-M enzymes. Antimicrob Agents Chemother, 48 : 1-14, 2004 [PMID : 14693512]
 
10) Jacoby GA : AmpC beta-lactamases. Clin Microbiol Rev, 22 : 161-82, Table of Contents, 2009 [PMID : 19136439]
 
11) Kohlmann R, et al : Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase. J Antimicrob Chemother, 73 : 1530-1536, 2018 [PMID : 29566147]
 
12) Cohen-Poradosu R & Kasper DL : Anaerobic Infections : General Concepts.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2923-2932, Elsevier, 2019
 
13) Garrett WS & Onderdonk AB : Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli).「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2969-2976, Elsevier, 2019
 
14) Kononen E : Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2977-2984, Elsevier, 2019
 
15) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2020年1月～12月 年報 院内感染対策サーベイランス 検査部門【外来検体】https://janis.mhlw.go.jp/report/open_report/2020/3/1/ken_Open_Report_202000_Outpatient.pdf
 
16) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2020年1月～12月 年報 院内感染対策サーベイランス 検査部門【入院検体】https://janis.mhlw.go.jp/report/open_report/2020/3/1/ken_Open_Report_202000.pdf
 
17) Moreillon P & Que YA : Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome).「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2393-2431, Elsevier, 2019
 
18) Rupp ME & Fey PD : Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2432-2443, Elsevier, 2019
 
19) Janoff EN & Musher DM : Streptococcus pneumoniae.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2473-2491, Elsevier, 2019
 
20) Murphy TF : Haemophilus Species, Including H. influenzae and H. ducreyi (Chancroid).「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2743-2752, Elsevier, 2019
 
21) Murphy TF : Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2628-2635, Elsevier, 2019
 
22) Araos R & D'Agata EMC : Pseudomonas aeruginosa and Other Pseudomonas Species.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2686-2699, Elsevier, 2019
 
23) Hochman S & Phillips M : Acinetobacter Species.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2718-2724, Elsevier, 2019
 
24) Greenberg D : Stenotrophomonas maltophilia and Burkholderia cepacia Complex.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2700-2705, Elsevier, 2019
 
25) Miller WR, et al : Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2492-2504, Elsevier, 2019
 
26) Holzman RS, et al : Mycoplasma pneumoniae and Atypical Pneumonia.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2332-2339, Elsevier, 2019
 
27) Edelstein PH & Roy CR : Legionnaires' Disease and Pontiac Fever.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp2807-2817, Elsevier, 2019
 
28) Lionakis MS &Edwards JE : Candida Species.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp3087-3102, Elsevier, 2019
 
P.81 掲載の参考文献
1) Doi Y : Penicillins and s-Lactamase Inhibitors.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp251-267, Elsevier, 2019
 
2) Paul M, et al : European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect, 28 : 521-547, 2022 [PMID : 34923128]
 
3) Tamma PD, et al : Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis, 18 : ciad428, 2023 [PMID : 37463564]
 
4) Lepak AJ & Andes DR : Cephalosporins.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp268-284, Elsevier, 2019
 
5) Doi Y : Ertapenem, Imipenem, Meropenem, Doripenem, and Aztreonam.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp285-290, Elsevier, 2019
 
6) Kuruvilla ME & Khan DA : Antibiotic Allergy.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp291-297, Elsevier, 2019
 
7) Mirakian R, et al : Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy, 45 : 300-327, 2015 [PMID : 25623506]
 
8) Uyttebroek AP, et al : Cefazolin Hypersensitivity : Toward Optimized Diagnosis. J Allergy Clin Immunol Pract, 4 : 1232-1236, 2016 [PMID : 27317018]
 
9) Chaudhry SB, et al : Cephalosporins : A Focus on Side Chains and β-Lactam Cross-Reactivity. Pharmacy (Basel), 7 : 103, 2019 [PMID : 31362351]
 
10) Blumenthal KG, et al : Antibiotic allergy. Lancet, 393 : 183-198, 2019 [PMID : 30558872]
 
11) Frumin J & Gallagher JC : Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics : what are the chances? Ann Pharmacother, 43 : 304-315, 2009 [PMID : 19193579]
 
12) Nesbitt WJ & Aronoff DM : Macrolides and Clindamycin.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp359-374, Elsevier, 2019
 
13) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2020年1月～12月 年報 院内感染対策サーベイランス 検査部門【外来検体】https://janis.mhlw.go.jp/report/open_report/2020/3/1/ken_Open_Report_202000_Outpatient.pdf
 
14) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2020年1月～12月 年報 院内感染対策サーベイランス 検査部門【入院検体】https://janis.mhlw.go.jp/report/open_report/2020/3/1/ken_Open_Report_202000.pdf
 
15) Zinner SH & Mayer KH : Sulfonamides and Trimethoprim ; Trimethoprim-Sulfamethoxazole.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp416-425, Elsevier, 2019
 
16) Hooper DC & Strahilevitz J : Quinolones.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp426-448, Elsevier, 2019
 
17) Moffa M & Brook I : Tetracyclines, Glycylcyclines, and Chloramphenicol.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp318-336, Elsevier, 2019
 
18) Nagel JL & Aronoff DM : Metronidazole.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp350-358, Elsevier, 2019
 

第2章 市中で感染症を診る～症候 / 疾患別アプローチ

P.111 掲載の参考文献
1) Metlay JP, et al : Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA, 278 : 1440-1445, 1997 [PMID : 9356004]
 
2) Metlay JP & Fine MJ : Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med, 138 : 109-118, 2003 [PMID : 12529093]
 
3) Syrjala H, et al : High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis, 27 : 358-363, 1998 [PMID : 9709887]
 
4) Esayag Y, et al : Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med, 123 : 88.e1-88.e5, 2010 [PMID : 20102999]
 
5) Self WH, et al : High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients : implications for diagnosing pneumonia. Am J Emerg Med, 31 : 401-405, 2013 [PMID : 23083885]
 
6) Claessens YE, et al : Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Respir Crit Care Med, 192 : 974-982, 2015 [PMID : 26168322]
 
7) 「成人市中肺炎診療ガイドライン」 (日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会/編), 杏林社, 2007
 
8) Gupta SK, et al : Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest, 120 : 1064-1071, 2001 [PMID : 11591540]
 
9) Cunha BA : The atypical pneumonias : clinical diagnosis and importance. Clin Microbiol Infect, 12 Suppl 3 : 12-24, 2006 [PMID : 16669925]
 
10) File TM Jr & Ramirez JA : Community-Acquired Pneumonia. N Engl J Med, 389 : 632-641, 2023 [PMID : 37585629]
 
11) File TM : Community-acquired pneumonia. Lancet, 362 : 1991-2001, 2003 [PMID : 14683661]
 
12) Ishiguro T, et al : Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Intern Med, 52 : 317-324, 2013 [PMID : 23370738]
 
13) Fukuyama H, et al : A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother, 19 : 719-726, 2013 [PMID : 23354936]
 
14) Halm EA, et al : Time to clinical stability in patients hospitalized with community-acquired pneumonia : implications for practice guidelines. JAMA, 279 : 1452-1457, 1998 [PMID : 9600479]
 
15) Metlay JP, et al : Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 200 : e45-e67, 2019 [PMID : 31573350]
 
16) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2022年1月～12月 年報 院内感染対策サーベイランス 検査部門【外来検体】https://janis.mhlw.go.jp/report/open_report/2022/3/1/ken_Open_Report_202200_Outpatient.pdf
 
17) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2022年1月～12月 年報 院内感染対策サーベイランス 検査部門【入院検体】https://janis.mhlw.go.jp/report/open_report/2022/3/1/ken_Open_Report_202200.pdf
 
P.128 掲載の参考文献
1) Bent S, et al : Does this woman have an acute uncomplicated urinary tract infection? JAMA, 287 : 2701-2710, 2002 [PMID : 12020306]
 
2) Nicolle LE, et al : Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 40 : 643-654, 2005 [PMID : 15714408]
 
3) Nicolle LE, et al : Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria : 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis, 68 : e83-e110, 2019 [PMID : 30895288]
 
4) Wang A, et al : Management Considerations in Infective Endocarditis : A Review. JAMA, 320 : 72-83, 2018 [PMID : 29971402]
 
5) Kim JS, et al : Relationship between uncommon computed tomography findings and clinical aspects in patients with acute pyelonephritis. Korean J Urol, 55 : 482-486, 2014 [PMID : 25045448]
 
6) Fukami H, et al : Perirenal fat stranding is not a powerful diagnostic tool for acute pyelonephritis. Int J Gen Med, 10 : 137-144, 2017 [PMID : 28507449]
PubMed
7) Tanizaki R, et al : Clinical impact of perinephric fat stranding detected on computed tomography in patients with acute pyelonephritis : a retrospective observational study. Eur J Clin Microbiol Infect Dis, 38 : 2185-2192, 2019 [PMID : 31372906]
 
8) Yu TY, et al : Computed tomography findings associated with bacteremia in adult patients with a urinary tract infection. Eur J Clin Microbiol Infect Dis, 35 : 1883-1887, 2016 [PMID : 27502931]
 
9) Meister L, et al : History and physical examination plus laboratory testing for the diagnosis of adult female urinary tract infection. Acad Emerg Med, 20 : 631-645, 2013 [PMID : 23859578]
 
10) Walter FG & Knopp RK : Urine sampling in ambulatory women : midstream clean-catch versus catheterization. Ann Emerg Med, 18 : 166-172, 1989 [PMID : 2916781]
 
11) Lammers RL, et al : Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med, 38 : 505-512, 2001 [PMID : 11679861]
 
12) Leman P : Validity of urinalysis and microscopy for detecting urinary tract infection in the emergency department. Eur J Emerg Med, 9 : 141-147, 2002 [PMID : 12131637]
 
13) van Nieuwkoop C, et al : Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis, 51 : 1266-1272, 2010 [PMID : 21034195]
 
14) Johnson JR & Russo TA : Acute Pyelonephritis in Adults. N Engl J Med, 378 : 48-59, 2018 [PMID : 29298155]
 
15) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2022年1月～12月 年報 院内感染対策サーベイランス 検査部門【外来検体】https://janis.mhlw.go.jp/report/open_report/2022/3/1/ken_Open_Report_202200_Outpatient.pdf
 
16) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2022年1月～12月 年報 院内感染対策サーベイランス 検査部門【入院検体】https://janis.mhlw.go.jp/report/open_report/2022/3/1/ken_Open_Report_202200.pdf
 
17) Headington JT & Beyerlein B : Anaerobic bacteria in routine urine culture. J Clin Pathol, 19 : 573-576, 1966 [PMID : 4288917]
 
18) Segura JW, et al : Anaerobic bacteria in the urinary tract. Mayo Clin Proc, 47 : 30-33, 1972 [PMID : 4550334]
 
19) Zimmermann P & Curtis N : The effect of antibiotics on the composition of the intestinal microbiota-a systematic review. J Infect, 79 : 471-489, 2019 [PMID : 31629863]
 
20) Maier L, et al : Unravelling the collateral damage of antibiotics on gut bacteria. Nature, 599 : 120-124, 2021 [PMID : 34646011]
 
21) Jacoby GA : AmpC beta-lactamases. Clin Microbiol Rev, 22 : 161-182, Table of Contents, 2009 [PMID : 19136439]
 
22) Kohlmann R, et al : Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase. J Antimicrob Chemother, 73 : 1530-1536, 2018 [PMID : 29566147]
 
23) Velasco M, et al : Blood cultures for women with uncomplicated acute pyelonephritis : are they necessary? Clin Infect Dis, 37 : 1127-1130, 2003 [PMID : 14523779]
 
24) van Nieuwkoop C, et al : Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis, 50 : e69-e72, 2010 [PMID : 20420504]
 
25) Coburn B, et al : Does this adult patient with suspected bacteremia require blood cultures? JAMA, 308 : 502-511, 2012 [PMID : 22851117]
 
26) Lutters M & Vogt-Ferrier NB : Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev : CD001535, 2008 [PMID : 18646074]
 
27) Eliakim-Raz N, et al : Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection--7 days or less versus longer treatment : systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother, 68 : 2183-2191, 2013 [PMID : 23696620]
PubMed
P.143 掲載の参考文献
1) Ebell MH, et al : Does This Patient Have Infectious Mononucleosis? : The Rational Clinical Examination Systematic Review. JAMA, 315 : 1502-1509, 2016 [PMID : 27115266]
 
2) Luzuriaga K & Sullivan JL : Infectious mononucleosis. N Engl J Med, 362 : 1993-2000, 2010 [PMID : 20505178]
 
3) Auwaerter PG : Infectious mononucleosis in middle age. JAMA, 281 : 454-459, 1999 [PMID : 9952206]
 
4) Manfredi R, et al : Primary cytomegalovirus infection in otherwise healthy adults with Fever of unknown origin : a 3-year prospective survey. Infection, 34 : 87-90, 2006 [PMID : 16703298]
 
5) Ishii T, et al : Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus : A single-center case-control study in Japan. J Infect Chemother, 25 : 431-436, 2019 [PMID : 30773381]
PubMed
6) Fiore AE, et al : Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 60 : 1-24, 2011 [PMID : 21248682]
 
7) 「-TG18 新基準掲載-急性胆管炎・胆嚢炎診療ガイドライン 2018 第3版」 (急性胆管炎・胆嚢炎診療ガイドライン改訂出版委員会/主催), 医学図書出版, 2018.
 
8) Gomi H, et al : Tokyo Guidelines 2018 : antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci, 25 : 3-16, 2018 [PMID : 29090866]
 
9) Kiriyama S, et al : TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci, 20 : 24-34, 2013 [PMID : 23307001]
 
10) 竹中完, 他 : 急性胆管炎・胆嚢炎の病態. 臨床消化器内科, 36 : 1109-1118, 2021
 
11) 藤澤聡郎, 他 : 急性胆管炎・胆嚢炎に対する抗菌薬選択. 臨床消化器内科, 36 : 1145-1151, 2021
 
12) Singh A, et al : Diagnostic Accuracy of MRCP as Compared to Ultrasound/CT in Patients with Obstructive Jaundice. J Clin Diagn Res, 8 : 103-107, 2014 [PMID : 24783094]
 
13) Bhattacharyya S, et al : Antibiotic-associated encephalopathy. Neurology, 86 : 963-971, 2016 [PMID : 26888997]
 
14) Appa AA, et al : Characterizing Cefepime Neurotoxicity : A Systematic Review. Open Forum Infect Dis, 4 : ofx170, 2017 [PMID : 29071284]
 
15) Payne LE, et al : Cefepime-induced neurotoxicity : a systematic review. Crit Care, 21 : 276, 2017 [PMID : 29137682]
 
16) Lin JN, et al : Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department : A matched case-control study. Acad Emerg Med, 17 : 1072-1079, 2010 [PMID : 21040108]
 
17) Sancho S, et al : Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis, 31 : 1791-1796, 2012 [PMID : 22167257]
 
18) Pavlaki M, et al : Polymicrobial bloodstream infections : Epidemiology and impact on mortality. J Glob Antimicrob Resist, 1 : 207-212, 2013 [PMID : 27873614]
 
19) Goldman S, et al : Risk Factors and Outcome of Polymicrobial Bacteremia : A Retrospective Cohort Study. Isr Med Assoc J, 22 : 279-284, 2020 [PMID : 32378818]
 
20) Tamma PD, et al : Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis, 18 : ciad428, 2023 [PMID : 37463564]
 
P.163 掲載の参考文献
1) Kumar M, et al : Cellulitis in older people over 75 years-are there differences? Ann Med Surg (Lond), 49 : 37-40, 2020 [PMID : 31867103]
 
2) Raff AB & Kroshinsky D : Cellulitis : A Review. JAMA, 316 : 325-337, 2016 [PMID : 27434444]
 
3) Silverberg B : A Structured Approach to Skin and Soft Tissue Infections (SSTIs) in an Ambulatory Setting. Clin Pract, 11 : 65-74, 2021 [PMID : 33535501]
 
4) Hua C, et al : Necrotising soft-tissue infections. Lancet Infect Dis, 23 : e81-e94, 2023 [PMID : 36252579]
 
5) Stevens DL & Bryant AE : Necrotizing Soft-Tissue Infections. N Engl J Med, 377 : 2253-2265, 2017 [PMID : 29211672]
 
6) Goh T, et al : Early diagnosis of necrotizing fasciitis. Br J Surg, 101 : e119-e125, 2014 [PMID : 24338771]
 
7) Borschitz T, et al : Improvement of a Clinical Score for Necrotizing Fasciitis : 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis. PLoS One, 10 : e0132775, 2015 [PMID : 26196941]
 
8) Peetermans M, et al : Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect, 26 : 8-17, 2020 [PMID : 31284035]
 
9) 日本衛生材料工業連合会 : トキシックショック症候群 医療従事者向けガイド. 2020 https://www.jhpia.or.jp/standard/tss/img/guide.pdf
 
10) Zacharias N, et al : Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg, 145 : 452-455, 2010 [PMID : 20479343]
 
11) Carbonetti F, et al : The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med, 121 : 106-121, 2016 [PMID : 26286006]
 
12) Bystritsky RJ : Cellulitis. Infect Dis Clin North Am, 35 : 49-60, 2021 [PMID : 33494874]
 
13) Peralta G, et al : Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis, 25 : 619-626, 2006 [PMID : 17047905]
 
14) Taniguchi T, et al : High Yield of Blood Cultures in the Etiologic Diagnosis of Cellulitis, Erysipelas, and Cutaneous Abscess in Elderly Patients. Open Forum Infect Dis, 9 : ofac317, 2022 [PMID : 35899281]
 
15) Bruun T, et al : Early Response in Cellulitis : A Prospective Study of Dynamics and Predictors. Clin Infect Dis, 63 : 1034-1041, 2016 [PMID : 27402819]
 
16) Swartz MN : Clinical practice. Cellulitis. N Engl J Med, 350 : 904-912, 2004 [PMID : 14985488]
 
17) Webb E, et al : Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N Engl J Med, 383 : 630-639, 2020 [PMID : 32786188]
 
18) Berbari EF, et al : 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis, 61 : e26-e46, 2015 [PMID : 26229122]
 
19) Beaman FD, et al : ACR Appropriateness CriteriaR Suspected Osteomyelitis, Septic Arthritis, or Soft Tissue Infection (Excluding Spine and Diabetic Foot). J Am Coll Radiol, 14 : S326-S337, 2017 [PMID : 28473089]
 
20) Dagirmanjian A, et al : MR imaging of vertebral osteomyelitis revisited. AJR Am J Roentgenol, 167 : 1539-1543, 1996 [PMID : 8956593]
 
21) Hatzenbuehler J & Pulling TJ : Diagnosis and management of osteomyelitis. Am Fam Physician, 84 : 1027-1033, 2011 [PMID : 22046943]
 
22) MD Anderson Cancer Center : staphylococcus aureus Bacteremia Management https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/clinical-management/clin-management-saureus-bacteremia-web-algorithm.pdf
 
23) Palraj BR, et al : Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) : Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis, 61 : 18-28, 2015 [PMID : 25810284]
 
24) Khatib R, et al : Persistence in Staphylococcus aureus bacteremia : incidence, characteristics of patients and outcome. Scand J Infect Dis, 38 : 7-14, 2006 [PMID : 16338832]
 
25) Kuehl R, et al : Defining persistent Staphylococcus aureus bacteraemia : secondary analysis of a prospective cohort study. Lancet Infect Dis, 20 : 1409-1417, 2020 [PMID : 32763194]
 
26) Minejima E, et al : Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. Clin Infect Dis, 70 : 566-573, 2020 [PMID : 30949675]
 
27) Tande AJ, et al : Osteomyelitis.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp1418-1429, Elsevier, 2019
 
28) Kamiya N, et al : Significance of repeat magnetic resonance imaging in diagnosing vertebral osteomyelitis. J Gen Fam Med, 20 : 68-71, 2019 [PMID : 30873308]
 

第3章 これだけはダメ ! 外来での感染症診療におけるNG行動

P.175 掲載の参考文献
1) Heikkinen T & Jarvinen A : The common cold. Lancet, 361 : 51-59, 2003 [PMID : 12517470]
 
2) Kenealy T & Arroll B : Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev, 2013 : CD000247, 2013 [PMID : 23733381]
 
3) Arroll B & Kenealy T : Are antibiotics effective for acute purulent rhinitis? Systematic review and meta-analysis of placebo controlled randomised trials. BMJ, 333 : 279, 2006 [PMID : 16861253]
 
4) Meropol SB, et al : Risks and benefits associated with antibiotic use for acute respiratory infections : a cohort study. Ann Fam Med, 11 : 165-172, 2013 [PMID : 23508604]
 
5) Turner RB : Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol, 78 : 531-539 ; quiz 539, 1997 [PMID : 9207716]
 
6) Uyeki TM, et al : Clinical Practice Guidelines by the Infectious Diseases Society of America : 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis, 68 : 895-902, 2019 [PMID : 30834445]
 
7) 厚生労働省 : 新型コロナウイルス感染症COVID-19診療の手引き 第10.0版. 2023 https://www.mhlw.go.jp/content/001136687.pdf
 
8) 厚生労働省健康・生活衛生局 感染症対策部 感染症対策課 : 抗微生物薬適正使用の手引き 第三版. 2023 https://www.mhlw.go.jp/content/10900000/001168459.pdf
 
9) 国立感染症研究所 : 百日咳の検査診断. 2019 https://www.niid.go.jp/niid/images/idsc/kikikanri/R1/2-01.pdf
 
10) Leung AK & Rafaat M : Eruption associated with amoxicillin in a patient with infectious mononucleosis. Int J Dermatol, 42 : 553-555, 2003 [PMID : 12839608]
 
11) Ebell MH, et al : Does This Patient Have Infectious Mononucleosis? : The Rational Clinical Examination Systematic Review. JAMA, 315 : 1502-1509, 2016 [PMID : 27115266]
 
12) 厚生労働省 院内感染対策サーベイランス (JANIS) : 公開情報2022年1月～12月 年報 院内感染対策サーベイランス 検査部門【外来検体】https://janis.mhlw.go.jp/report/open_report/2022/3/1/ken_Open_Report_202200_Outpatient.pdf
 
13) Regina CG, et al : Syndromes of Enteric Infection.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp1330-1339, Elsevier, 2019
 
14) Bartelt LA, et al : Diarrhea With Little or No Fever.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp1346-1356, Elsevier, 2019
 
15) Lima AA, et al : Acute Dysentery Syndromes (Diarrhea With Fever).「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp1357-1364, Elsevier, 2019
 
16) Wong KK, et al : Foodborne Disease.「Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition」 (Bennett JE, et al, eds), pp1380-1394, Elsevier, 2019
 
P.180 掲載の参考文献
1) Wright WF : chapter 56 Fever of Unknown Origin. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 9th ed. pp790-800, Elsevier, 2019
 
2) Gupta S, et al : Culture-Negative Severe Sepsis : Nationwide Trends and Outcomes. Chest, 150 : 1251-1259, 2016
PubMed
3) Haidar G & Singh N : Fever of Unknown Origin. N Engl J Med, 386 : 463-477, 2022
PubMed
4) Susilawati TN & McBride WJ : Acute undifferentiated fever in Asia : a review of the literature. Southeast Asian J Trop Med Public Health, 45 : 719-726, 2014
 
5) Petersdorf RG & Beeson PB : Fever of unexplained origin : report on 100 cases. Medicine (Baltimore), 40 : 1-30, 1961
PubMed
6) Cunha BA : Fever of unknown origin : clinical overview of classic and current concepts. Infect Dis Clin North Am, 21 : 867-915, vii, 2007
 
7) Wang A, et al : Management Considerations in Infective Endocarditis : A Review. JAMA, 320 : 72-83, 2018
PubMed
P.182 掲載の参考文献
1) Wright WF : chapter 56 Fever of Unknown Origin. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 9th ed. pp790-800, Elsevier, 2019
 
2) Haidar G & Singh N : Fever of Unknown Origin. N Engl J Med, 386 : 463-477, 2022
PubMed
3) Durack DT & Street AC : Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis, 11 : 35-51, 1991
PubMed
4) Horowitz HW : Fever of unknown origin or fever of too many origins? N Engl J Med, 368 : 197-199, 2013
PubMed
5) Vanderschueren S, et al : From prolonged febrile illness to fever of unknown origin : the challenge continues. Arch Intern Med, 163 : 1033-1041, 2003
PubMed

書評

最近チェックした商品履歴

Loading...